ANIK vs IR · rev $62.2M vs P/E 49, rev $3.90B
Anika Therapeutics Inc (ANIK) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
ANIK currently screens at market cap $161.3M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the ANIK and IR stock pages for the full models.
Not investment advice.